We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-2.54%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$49.4B
AUM Growth
-$1.83B
(-3.6%)
Cap. Flow
+$236M
Cap. Flow
% of AUM
0.48%
Top 10 Holdings %
Top 10 Hldgs %
23.11%
Holding
2,899
New
506
Increased
652
Reduced
806
Closed
772
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.93B |
| 2 |
Kenvue
KVUE
|
+$537M |
| 3 |
Humana
HUM
|
+$477M |
| 4 |
AbbVie
ABBV
|
+$441M |
| 5 |
Microsoft
MSFT
|
+$384M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$747M |
| 2 |
Apple
AAPL
|
+$565M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$467M |
| 4 |
McKesson
MCK
|
+$347M |
| 5 |
Intel
INTC
|
+$300M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.79% |
| 2 | Healthcare | 17.06% |
| 3 | Consumer Discretionary | 12.96% |
| 4 | Consumer Staples | 7.45% |
| 5 | Financials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Signet Jewelers
SIG
$3.72B
| $926K | ﹤0.01% |
+12,896
| New | +$957K |
|
1502
Rekor Systems
REKR
$86M
| $925K | ﹤0.01% |
+327,873
| New | +$1,000K |
|
|
BCSAW
1503
CALL
DELISTED
Blockchain Coinvestors Acquisition Corp. I Warrant
BCSAW
| $924K | ﹤0.01% |
85,247
| – | – |
|
1504
Beyond Meat
BYND
$283M
| $922K | ﹤0.01% |
+95,862
| New | +$1.25M |
|
1505
Oxford Square Capital
OXSQ
$148M
| $914K | ﹤0.01% |
303,568
+65,346
| +27% | +$198K |
|
1506
BNY Mellon US Large Cap Core Equity ETF
BKLC
$5.43B
| $910K | ﹤0.01% |
+33,720
| New | +$940K |
|
1507
Opko Health
OPK
$936M
| $903K | ﹤0.01% |
564,533
-129,200
| -19% | -$235K |
|
1508
Viant Technology
DSP
$226M
| $901K | ﹤0.01% |
160,893
+134,480
| +509% | +$736K |
|
|
GGAAW
1509
CALL
DELISTED
Genesis Growth Tech Acquisition Corp. Warrant
GGAAW
| $901K | ﹤0.01% |
74,999
| – | – |
|
1510
Caterpillar
CAT
$402B
| $901K | ﹤0.01% |
3,299
-143,044
| -98% | -$38.8M |
|
1511
Tennant Co
TNC
$1.48B
| $900K | ﹤0.01% |
12,140
-5,874
| -33% | -$468K |
|
1512
Globalstar
GSAT
$10.2B
| $896K | ﹤0.01% |
45,574
-44,342
| -49% | -$795K |
|
|
CFFSW
1513
CALL
DELISTED
CF Acquisition Corp. VII Warrant
CFFSW
| $895K | ﹤0.01% |
83,598
| – | – |
|
|
ECXWW
1514
CALL
ECARX Holdings Warrants
ECXWW
| $891K | ﹤0.01% |
287,342
-34,070
| -11% | -$2.13K |
|
1515
Paychex
PAYX
$41.1B
| $889K | ﹤0.01% |
7,711
-175,826
| -96% | -$21.2M |
|
1516
Central Garden & Pet Co
CENT
$2.71B
| $886K | ﹤0.01% |
25,095
+11,467
| +84% | +$394K |
|
|
USCTW
1517
CALL
DELISTED
Roth CH Acquisition Co. Warrant
USCTW
| $880K | ﹤0.01% |
80,567
-4,401
| -5% | -$290 |
|
1518
Crinetics Pharmaceuticals
CRNX
$8.87B
| $877K | ﹤0.01% |
+29,500
| New | +$608K |
|
1519
Bioventus
BVS
$843M
| $874K | ﹤0.01% |
264,949
+194,178
| +274% | +$681K |
|
|
HLLY.WS
1520
CALL
DELISTED
Holley Inc Warrants
HLLY.WS
| $873K | ﹤0.01% |
175,000
-50,000
| -22% | -$43.4K |
|
1521
DXP Enterprises
DXPE
$2.57B
| $870K | ﹤0.01% |
24,900
-15,309
| -38% | -$553K |
|
1522
Fair Isaac
FICO
$29.7B
| $869K | ﹤0.01% |
1,000
-11,495
| -92% | -$9.87M |
|
1523
Laureate Education
LAUR
$5.25B
| $867K | ﹤0.01% |
61,497
-206,467
| -77% | -$2.77M |
|
|
CPRX
1524
DELISTED
Catalyst Pharmaceutical
CPRX
| $865K | ﹤0.01% |
73,991
-120,012
| -62% | -$1.61M |
|
1525
Mueller Industries
MLI
$14.2B
| $864K | ﹤0.01% |
+45,960
| New | +$910K |
|
Similar funds
Marshall Wace's Q3 2023 Portfolio in Review
As of Q3 2023, Marshall Wace held 2,899 positions worth $49.4B, down 3.6% from $51.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Marshall Wace's Q3 2023 filing shows 506 new, 652 increased, 806 reduced and 772 closed positions. Its largest new stake was Humana: 1,014,185 shares worth $493M. The largest sale was Amazon, an estimated $747M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q3 2023 buy was Humana: 1,014,185 shares worth $493M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q3 2023, an estimated $1.93B increase.
- Marshall Wace's biggest Q3 2023 reduction was Amazon, cutting an estimated $747M.
- Marshall Wace fully exited Johnson & Johnson in Q3 2023, selling an estimated $284M.
- Marshall Wace's ten largest holdings make up 23% of its $49.4B portfolio in Q3 2023.
- Marshall Wace opened 506 new positions and closed 772 in Q3 2023.
- Marshall Wace's portfolio value fell 3.6% quarter-over-quarter to $49.4B.
Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.